Subscribe to VETERINARY PRACTICE NEWS   SUBSCRIBER SERVICES    Bookmark and Share
VPN Logo   
 Home   About Us   Contact Us
2:21 PM   April 24, 2014
Your E-mail:
 

 
Bookmark and Share
Pfizer Unveils Product Details of Fort Dodge Acquisition

Posted: Monday, Oct. 19, 2009, 4:33 p.m., EDT

Pfizer Unveils Product Details of Fort Dodge Acquisition Pfizer Animal Health of New York on Oct. 19 released a summary of its new U.S. product portfolio as a result of Pfizer’s recent acquisition of Wyeth and its subsidiary Fort Dodge Animal Health.

Pfizer and Wyeth began joint operations on Oct. 16.

With the acquisition, Pfizer Animal Health reports that it now offers an enhanced portfolio in beef, dairy and companion animals, as well as a redefined product line for swine, equine and poultry.

Pfizer Animal Health’s new U.S. product portfolio summary includes:

Livestock

  • Beef and diary - Factrel (gonadorelin hydrochloride) and the line of Synovex implants, which the company said complements the current U.S. cattle portfolio, such as Draxxin (tulathromycin), Dectomax, Excede (ceftiofur crystalline free acid), Excenel (cefriofur hydrochloride), Bovi-Shield Gold, Lutalyse (dinoprost tromethamine), Orbeseal and Spectramast (ceftiofur hydrochloride).
    .
  • Swine – Suvaxyn brands, including Suvaxyn PCV-2 vaccine for circovirus. The company said this addition rounds out the line of Respisure, Flusure, Draxxin and Excede.
    .
  • Poultry – The acquisition adds a broad range of poultry vaccines, including Poulvac and Maternavac IBD-Reo, a broiler-breeder vaccine.

Equine

West Nile Innovator, Flu Vac Innovator and Quest (moxidectin) and Quest Plus (moxidectin/praziquantel), additions to Pfizer Animal Health’s Strongid (pyrantel pamoate), Dormosedan (detomidine hydrochloride) and Hylartin (sodium hyaluronate).

Companion Animals

The acquisition brings in the vaccine Lymevax, which complements the current Vanguard canine vaccine line, as well as several anesthetic products. These products join current offerings such as Revolution (selamectin), Cerenia (maropitant citrate), Convenia (cefovecin sodium), Rimadyl (carprofen) and Slentrol (dirlotapide).

Pfizer Animal Health also reported that all current U.S. pricing, product distribution, programs and policies for its products, including the acquired Fort Dodge products, will remain in place through the end of the year. <HOME>

Related News: Pfizer Closes Wyeth Acquisition Deal

 Give us your opinion on
Pfizer Unveils Product Details of Fort Dodge Acquisition

Submit a Comment

Industry Professional Site: Comments from non-industry professionals will be removed.

Click here to subscribe

Subscriber Services

See all veterinary videos
Featured Vet Grooming Video 
Video Button
Facebook
BROUGHT TO YOU BY Veterinary Practice News

Copyright ©   I-5 Publishing, LLC. All rights reserved.
Our Privacy Policy has changed.
PRIVACY POLICY/YOUR CALIFORNIA PRIVACY RIGHTS.
Terms of Use | Guidelines for Participation

Gold Standard

*Content generated by our loyal visitors, which includes comments and club postings, is free of constraints from our editors’ red pens, and therefore not governed by I-5 Publishing, LLC’s Gold Standard Quality Content, but instead allowed to follow the free form expression necessary for quick, inspired and spontaneous communication.